ホルモン補充療法市場：治療タイプ別、投与経路別、用途別、流通チャネル別、地域別

世界のホルモン補充療法市場は、2024年には148億9,000万米ドルと推定され、2031年には220億4,000万米ドルに達すると予測され、2024年から2031年までのCAGRは5.8%です。

図.ホルモン補充療法市場シェア（%）、地域別、2024年

世界のホルモン補充療法市場は、世界中の女性の間で更年期障害の有病率が上昇していることから、過去数年間で大きな成長を遂げています。ホルモン補充療法は、ほてり、寝汗、膣乾燥、性欲減退、気分の落ち込みなど、更年期以降に経験するさまざまな症状の治療に役立ちます。ホルモンバランスの乱れや加齢に起因する骨粗鬆症やその他の慢性疾患に関する健康上の懸念の高まりが、効果的な治療ソリューションに対する需要を牽引しています。さらに、女性の健康問題に対する意識の高まりと、様々なホルモン補充剤製剤の入手可能性が、予測期間中の市場拡大を促進すると予想されます。しかし、ホルモン剤の長期使用に伴う副作用や代替治療オプションの利用可能性などの要因は、引き続き市場の成長をある程度阻害しています。

市場力学：

世界のホルモン補充療法市場を促進する主な要因としては、ホルモン欠乏症の影響を受けやすい老年人口の急増、女性の更年期発症率の上昇、世界の生活習慣病の急増、慢性疾患管理におけるホルモン補充療法の利点に関する認知度の向上などが挙げられます。一方、乳がん、心臓病、脳卒中、血栓を含むホルモン剤の長期使用に伴う副作用は、市場関係者に大きな課題を突きつけています。しかしながら、新規ドラッグデリバリーシステムの開発、様々なホルモンの組み合わせ、バイオアイデンティカルホルモン製剤の革新に向けた研究開発の進行は、今後数年間、利害関係者にとって有利な成長機会をもたらすと期待されています。

本調査の主な特徴

• 本レポートでは、世界のホルモン補充療法市場を詳細に分析し、2023年を基準年とした予測期間（2024-2031年）の市場規模と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競合戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界のホルモン補充療法市場の主要企業をプロファイルしています。
• 主要企業には、Novartis AG、Abbott、Mylan NV、Merck KgaA、Bayer AG、Pfizer Inc.、Novo Nordisk A/S、QuatRx Pharmaceuticals、Teva Pharmaceutical Industries Ltd.、Amgen, Inc.、Eli Lilly and Company、Halozyme Therapeutics, Inc.、AbbVie, Inc.、Noven Pharmaceuticals, Inc.、i-MAB Biopharma Co.
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界のホルモン補充療法市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界のホルモン補充療法市場の分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• メーカー収益
• 非侵襲性センサー技術の採用
• 買収と提携のシナリオ
• 製品の発売/承認
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界のホルモン補充療法市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界のホルモン補充療法市場、療法タイプ別、2019年-2031年

• エストロゲン補充療法
• ヒト成長ホルモン（HGH）補充療法
• 甲状腺補充療法
• テストステロン補充療法
• その他

第6章 世界のホルモン補充療法市場、投与経路別、2019年-2031年

• 経口
• 非経口
• その他

第7章 世界のホルモン補充療法市場、用途別、2019年-2031年

• 甲状腺機能低下症
• 男性性腺機能低下症
• 成長ホルモン欠乏症
• その他

第8章 世界のホルモン補充療法市場、流通チャネル別、2019年-2031年

• 病院薬局
• 小売薬局
• オンライン薬局

第9章 世界のホルモン補充療法市場、地域別、2019年-2031年

第10章 競合情勢

• 企業プロファイル
  • Novartis AG
  • Abbott
  • Mylan NV
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Halozyme Therapeutics, Inc.
  • AbbVie, Inc.
  • Noven Pharmaceuticals, Inc.
  • I-MAB Biopharma Co., Ltd.
  • Myovant Sciences

第11章 アナリストの見解

• Wheel of Fortune
• アナリストの見解
• Coherent Opportunity Map

第12章 参考文献と調査手法

• 参考文献
• 調査手法

The global hormone replacement therapy market is estimated to be valued at USD 14.89 Bn in 2024 and is expected to reach USD 22.04 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Figure. Hormone Replacement Therapy Market Share (%), By Region, 2024

The global hormone replacement therapy market has been witnessing significant growth over the past few years owing to the rising prevalence of menopause among women worldwide. Hormone replacement therapy helps treat various symptoms experienced during and after menopause like hot flashes, night sweats, vaginal dryness, low libido, and mood swings. Growing health concerns pertaining to osteoporosis and other chronic diseases due to hormonal imbalance and aging are driving the demand for effective therapeutic solutions. Furthermore, increasing awareness about women's health issues and availability of various hormone replacement drug formulations are expected to propel the market expansion during the forecast period. However, factors like side effects associated with long-term usage of hormones and availability of alternative treatment options continue to impede the market growth to a certain extent.

Market Dynamics:

The key drivers fueling the global hormone replacement therapy market include rapidly growing geriatric population susceptible to hormonal deficiencies, rising incidence of menopause among women, upsurge in lifestyle diseases globally, and increasing awareness about benefits of hormone replacement therapy in chronic disease management. On the other hand, side effects pertaining to long-term usage of hormones including Breast cancer, heart disease, stroke, and blood clots pose major challenges for market players. However, ongoing R&D towards development of novel drug delivery systems, combining various hormones, and innovation in bioidentical hormone formulations are expected to unlock lucrative growth opportunities for stakeholders in coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this includes Novartis AG, Abbott , Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., Eli Lilly and Company, Halozyme Therapeutics, Inc., AbbVie, Inc., Noven Pharmaceuticals, Inc., I-MAB Biopharma Co., Ltd., and Myovant Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global hormone replacement therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation-

• By Therapy Type:
  • Estrogen Replacement Therapy
  • Human Growth Hormone (HGH) Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
  • Others
• By Route of Administration:
  • Oral
  • Parenteral
  • Others
• By Application:
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Novartis AG
  • Abbott
  • Mylan NV
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Halozyme Therapeutics, Inc.
  • AbbVie, Inc.
  • Noven Pharmaceuticals, Inc.
  • I-MAB Biopharma Co., Ltd.
  • Myovant Sciences

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Adoption of Non-invasive Sensor Technologies
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Estrogen Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Human Growth Hormone (HGH) Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Thyroid Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Testosterone Replacement Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Hormone Replacement Therapy Market, By Route of Administration, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Hormone Replacement Therapy Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hypothyroidism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Male Hypogonadism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Growth Hormone Deficiency
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Hormone Replacement Therapy Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Novartis AG*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
  • Mylan NV
  • Merck KgaA
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • QuatRx Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Amgen, Inc.
  • Eli Lilly and Company
  • Halozyme Therapeutics, Inc.
  • AbbVie, Inc.
  • Noven Pharmaceuticals, Inc.
  • I-MAB Biopharma Co., Ltd.
  • Myovant Sciences

11. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact